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Catecholamine Release as Mediator of
Intracellular Enzyme Activation in Ischaemic
Perfused Rat Hearts
F. S. HO GH.
SUMMARY
Isolated rat hearts perfused at suboptimal pressures have
been studied as a model for generalised myocardial
ischaemia. Glycogen phosphorylase a and hormone-sensi-
tive triglyceridase activities, measured as markers for
endogenous catecholamine release, were significantly in-
creased at low perfusion pressures.
Pharmacological blockage of noradrenaline re-uptake
accentuated these effects, and depletion of ca:echolamine
reserves eliminated them. This phenomenon may be im-
portant in the pathophysiology of cardiac ischaemia and
its serious complications.
S. Air. Med. J., 49, 538 (1975).
orepinephrine ( E) homeostasis is a fundamental regula-
tory component of the contractile machinery and the inter-
mediary metabolism of the heart. Functioning as a neuro-
endocrine organ, the heart is capable of synthesising and
packaging dopamine into storage vesicles for enzymatic
conversion into NE, of transporting these vesicles to the
terminal bOlltons via the microtubular apparatus of the
adrenergic axons, and of releasing stored vesicle contents
by the process of exocytosis, upon appropriate stimulation.
Released E interacts with membrane receptors on post-
synaptic effector cells, while termination of effects is
mediated mainly by rapid cellular uptake, which leads to
degradation by intracellular monoamine oxidase and other
enzymes, or to storage for future release.'
It has now become well established that the intracellular
effects of catecholamines are mediated largely by variations
in the concentration of cyclic AMP (cAMP), which
reflect a fine balance between synthesis via the hormone-
sensitive membrane enzyme, adenyl cyclase, and degrada-
tion by a family of nucleotide phosphodiestera e iso-
enzymes.' cAMP activates a number of protein kinases.
which phosphorylate specific key intracellular proteins.
including certain regulatory contractile proteins (troponins),
glycogen phosphorylase. triglyceridase and certain mem-
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brane proteins involved in Ca'· fluxes; all these are in
turn dephosphorylated by specific phosphatases.'
Although catecholamines are essential for normal cardiac
function, excessive release can cau e functional and struc-
tural damage to the heart. Recently reported catechola-
mine-mediated cardiomyopathies in both experimental
animal models (isoproterenol cardiomyopathy') and in
clinical medicine (phaeochromocytoma, tetanus, cardiac
surgery"). prompted us to examine the effect of ischaemia
on catecholamine release in the isolated rat heart.
In this study, use has been made of the known
timulatory effect of catecholamines on cardiac glyco-
genolysis and lipolysis,' activation of the respectively
rate-limiting enzymes glycogen pho phorylase and hor-
mone-sensitive triglyceride lipase (HSL) being used as
indirect parameters of NE release. These enzyme activities
were characterised. and particular care was taken to
ensure that contaminating lipoprotein lipase was not
measured. Rat hearts, perfused at Iow pressure by the
retrograde Langendorff procedure, served as working
models for myocardial ischaemia, and the effects on these
enzymes were evaluated by comparisons with hearts per-
fused at normal pressures. Finally, the question as to whether
observed changes were indeed catecholamine-mediated was
examined by testing the effects in this system of: (a)
inhibiting catecholamine uptake and subsequent degra-
dation, and (b) depleting cardiac catecholamine stores by
reserpine pretreatment, or by prolonged perfusion.
METHODS
Periusion Technique and Tissue Preparation
After an overnight fast (12 - 20 h), inbred albino Wistar
rats (150 - 250 g) of both sexes were anaesthetised by
intraperitoneal injection of pentobarbital sodium (30 mg/
kg) and the hearts were rapidly removed 30 minutes later, to
be perfused at 37°C by the Langendorff technique, using
Krebs-Ringer bicarbonate medium gassed with 95% 0,:
5°:' CO, and containing 15 mM glucose.' Routine perfusions
were carried out for 30 minutes at a constant perfusion
pressure of 70 mmHg. Low-pressure perfusions, unless
otherwi e specified, consisted of an initial lO-minute
perfusion at 70 mmHg, followed by 20 minutes at 20
mmHg.
Perfused hearts were blotted dry and vertically halved and
the two parts were homogenised respectively in 10 vo!. of
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buffer A (20 mM N-2-hydoxyethylpiperazine-N-2-ethane-
ulphonate (Hepes), 20 mM KF, 1 mM EOTA; pH 6,1)
and 7,5 vo!. of buffer B (0.25M sucrose. 30 mM EOTA,
0.2°0 bovine serum albumin (RS.A.). 15 mM sodium
phosphate; pH 6,8), for 3 x 10 sec in the cold, at half-
maximum speed with a Polytron PT I0 homogeniser.
The homogenates were centrifuged at l'C. first at I 000 g
for 10 minutes and then at 12 500 g for a further 10
minutes.
Glycogen Phosphorylase and Triglyceride Lipase
Detenninations
a dual action. fluoride ion are known to cause the
activation of adenyl cyclase as well a the inhibition of
Mg"-dependenr phosphatase.' It should be noted that
inclu ion of 20 m 1 KF. in combination with the chelating
agent EDTA. brought about atisfactory stabilisation of
phosphorylase a activity without the undue stimulation
of adenyl cyclase obtained in the presence of 100 mM KF.
Decapitation. with its accompanying burst of adrenergic
activity.''' gave incon i tently high phosphorylase {/ values.
and barbiturate anae thesia wa accordingly preferred.
Perfusion of isolated hearts gave both the mo t repro-
ducible baseline. and the highest catecholamine-stimulated
phosphorylase a activitie .
TA8LE I. GLYCOGEN PHOSPHORYLASE ACTIVITY IN
DIFFERENT RAT HEART PREPARATIONS
Lipase activity, as determined by glycerol release, was
present in both the crude mitochondrial and the post-
mitochondrial supernatant fractions, acting on a variety of
substrates (Table 11). No attempt was made to characterise
these enzymes in detail, although definite qualitative and
quantitative differences between the mitochondrial and
supernatant enzymes were observed. Using tributyrin as
substrate, prior fasting of animals was found to lead to
higher activities of both kinds of lipases, this activation
being more pronounced in the mitochondrial fraction.
Addition of NH,Cl (20 mM) to the as ay mixture gave
similar results. Of particular intere t was the timulation of
the mitochondrial but not of the supernatant lipase by
heparin. a known activator of lipoprotein lipa e." This latter
enzyme. predominantly present in the cytoplasm. is inhi-
bited by the EDTA and sodium pho phate used in our
assay, however. and is only weakly active at a pH below
7.0 in the absence of serum ubstrate. Furthermore, aF,
a potent inhibitor of adipose tis ue and hepatic mito-
chondrial lipa es" has no effect on lipoprotein lipase.
wherea a definite inhibition wa observed in both our
enzyme fraction.
Phosphorylase a
Immediate Assayed
assay after 24 h
Glycogen phosphorylase: The postmitochondrial super·
natant in buffer A was used for phosphorylase determi-
nations in the absence (phosphorylase a activity) and
presence (total phosphorylase activity) of 5'-AMP, by a
micro-modification of the method of Hers and van Hoof.'
using 50-Ill volumes of assay mixture and tissue extracl.
respectively. Inorganic phosphate formed was determined
colorimetrically.·
Triglyceride lipases: The postmitochondrial supernatant
and the crude mitochondrial fractions prepared in buffer
B were incubated in buffer C (20 mM Hepes, 2°:, B.S.A ..
15 mM mercapto-ethano!. 30 mM EOTA; pH 6.8) which
also contained 10 mM substrate (pure glyceride in 0,5%
BS.A., after high-speed sonication with a Branson Sonifier,
Mark IV), in a shaking waterbath for 60 or 90 minutes at
30'C. The mitochondrial sediment was resuspended in
buffer B and sonicated (5 x 10 sec. low etting 5), prior
to incubation. The reaction was terminated by the addition
of 0.1 vo!. of 30°{, cold perchloric acid. followed by high-
speed centrifugation; perchlorate ion were removed.
following neutralisation with KOH. by means of pressure
filtration (Sartorius syringe filter; 0.45 p.1). The clear
upernatant was used for the determination of glycerol
by the double enzymatic method of Wieland: with the
principal modification of the addition of 20 mM 19CI, to
overcome EOTA inhibition. The justifiable assumption was
made that triglyceridase, and not diglyceridase or mono-
glyceridase activity, was rate-limiting for the production
of glycerol.
Manipulation of Cardiac Catecholamine Stores
Inhibition of catecholamine uptake and degradation
was accomplished by the addition to the perfusion medium
of 20 p.M phenoxybenzamine (PBA solution for injection),
a known inhibitor of both neuronal and extraneuronal
uptake processes,' immediately prior to mounting the heart.
Catecholamine stores were depleted in vil·o by the
intraperitoneal injection of reserpine (Serpasil 5 mg/kg)
2 hours prior to perfusion. a well a ill situ by prolonged
perfu ion (see Fig. 4).
RESULTS
Table I illustrates some basic characteristic of the cAM P-
dependent glycogen phosphorylase y tem. By means of
(i) Hearts from decapitated rats, with
phosphorylase assay carried out
in 20 mM Hepes alone '"
(ii) As (i) but with 100 mM KF ...
(iii) As (i) but with 20 mM KF + 1
mM EDTA
(iv) Anaesthesia with pentobarbital
sodium (no decapitation), enzyme
assayed in tOO mM KF + 20 mM
Hepes
(v) Isolated heart perfused for 30
min; enzyme in 15 - 30 mM KF
(vi) Epinephrine, administered in vivo
(5 - 10 P.9 by intracardiac or IV
injection)
or in vitro (0,1 - 0,2 P.9 in perfu-
sion medium) .
t 7 - 28'10
70%
34/
58%
4 - 20'j,
50 - 78'10
25 - 40%
10'1
48/"o
34'1
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TABLE 11. CHARACTERISATION OF CARDIAC L1PASES
• cAMP 2.5 JiM. ATP 0.15 mM. MgCI, 20 mM. and caffe'ne (or theo·
phylline) 2.5 mM.
(B) Modulatio:1 of lipase activity (using
tributyrin as s:Jbstr<:te)
(i) NaF (20 mM) 74 71
(ii) Heparin (80 IU/ml) 125 100
(iii) NH.CI (20 mM) 168 138
(iv) cAMP - ATP - Mg - cilffeine (in
vitro)* 500 200
(v) Epinephrine:
in vivo (25 fL9 IV) 500 200
or in situ (0,2 fL9/ml perfusion
medium) 190 140
,/,:" of total
activity in
-
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Fig. 1. The effect of ischaemia on cardiac glycogen
phosphorylase. All perfusions were carried out for 30
minutes as described under 'Methods'. In the control
experiments (0), the perfusion pressure during the entire
30 minutes was maintained at 70 mmHg. In the ischaemic
cases, the duration of low-pressure perfusion varied from
10 to 30 minutes, as indicated.
suggesting a common mode of action. rather than inde-
pendent actions causing additive changes.
Similar results were obtained in the case of lipase assays.
Prolonged perfusion of rat hearts gradually depleted
cardiac catecholamine stores. A marked ischaemic activa-
tion of phosphorylase was still observed after 35 minutes
of perfusion but no stimulation was found after 75
minutes (Fig. 4). Similar re ults were obtained after ill vivo
catecholamine depletion by means of reserpine adminis-
tration (Figs 5 and 6). Whereas activation of glycogen
phosphorylase and lipase by low-pressure perfusion was
observed in non-reserpini ed animals, reserpine pretreat-
ment completely abolished the stimulation by ischaemia.
The inhibitory effect of ischaemia on the supernatant
lipase with tributyrin as substrate (Fig. 2) was not
significantly affected by reserpinisation, however (Fig. 6).
The higher phosphorylase a and lipase values of reserpi-
nised control hearts probably reflected catecholamine re-
lease by the drug, as illustrated by the stimulatory effect
of 20 j1.g reserpine added to the perfusion system of a
non-ischaemic control heart (Fig. 5).
Hormone sensitivity was ascertained by the ill I'itro
incubation of enzyme fractions with cAMP, ATP. MgCl,
and the phosphodiesterase inhibitor caffeine (or theophyl-
line), by ill I'il'o injection of epinephrine as described
above, and by the ill situ addition of catecholamine to
the perfusion medium. Both lipase enzyme fractions res-
ponded to hormone stimulation by two- to tllreefold
increased activities. and an activation ratio of 5: 2
between mitochondrial and upernatant lipases was obtain-
ed in all three experiments.
The effect of ischaemia on glycogen phosphorylase and
lipase activities of perfused rat hearts is illustrated in
Figs 1 and 2. A consistent activation of glycogen phos-
phorylase was observed, and was most marked with a low-
pressure perfusion lasting 20 minutes. The average stimula-
tion under these conditions was 50 - 90o~ (9 experiments).
Using triolein as substrate, both the mitochondrial and
s~pernatant lipases in ischaemic tissue showed increased
activitie . giving results similar to those obtained in vitro
and in l'il'O by lipase activation with epinephrine (Table IT).
With tributyrin as substrate, however. perfusion at low
press'.'re en~an~ed the a~tivity of the mitochondrial lipase
only, whi!e it inhibited the supernatant enzyme.
Before concluding that norepineohrine release mediated
the observei enzyme activations during ischaemia. direct
non-catecholamine-related influences (e.g. hypoxia) had to
be examined. Fig. 3 illustrates the effect of low-pressure
perfusion and phenoxybenzamine (PBA) on glycogen phos-
phorylase activation. When used in combination, the
observed enzyme activation exceeded the sum of the
activations produced by the two individual treatment,
DURATION OF ISCHAEMIA (MIll.)
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250
Fig. 4. The effect of prolonged perfusion on cardiac
glycogen phosphorylase. Control hear:s (0--0) were
perfused for 15, 35, 55 and 75 minutes. Ischaemic hearts
(0- - -0) were perfused for either 15, 35 or 55 minutes,
followed in each case by a 20-minute ~eriod at low
pressure. Figures indicate the percentage stimulation of
glycogen phosphorylase aCliYities after 35, 55 and 75
minutes of perfusion.
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Fig. 5. The effect of reserpine if! vivo (5 mg g intra-
peritoneally) and in situ (20 ,ug added to perfusion medium)
on glycogen phosphorylase actiYi(y in control (C) and
ischaemic (I) hearts.
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Fig. 2. The effect of ischaemia on cardiac hormone-
sensitiYe Iipases. Hearts were perfused at low pressure for
20 minutes, as described under 'Methods'. Lipase determi-
nations were done using triolein (TO) and tributyrin (TB)
as substrates, and were expressed as percentages of control
values. Figures in parentheses indicate number of
experiments.
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Fig. 3. The effect of phenoxybenzamine (PBA) and low-
pressure perfusion on glycogen phosphorylase. PBA
(20 ,uM) added to perfusion medium immediately prior
to perfusion carried out as described under 'Methods':
(A) effect of low-pressure perfusions; (B) PBA effect;
(C) theoretical sum of iow-pressure perfusion + PBA;
(D) obseryed effect of low-pressure perfusion + PBA.
Processes involved in cardiac catecholamine metabolism
constitute an important link between the maintenance of
normal heart functions and the development of myocardial
diseases. Thus catecholamines are of major importance in
the regulation of myocardial energy production (glycolysis,
lipolysis') and energy utilisation (membrane Ca" fluxe ;
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ISCHAEMIA
mine mediation. Considering that ischaemia may be accom-
panied both by catecholamine release and by hypoxia, it
is possible that the potent antilipolytic effect of hypoxia"
could have accounted for this apparent inhibition, raising
the interesting possibility of differential lipase activation
and selective free fatty acid liberation during ischaemia.
Increased catecholamine release during ischaemia may
have serious effects on heart functions. Although glycolysis
and glycogen depletion have been implicated in the
pathogenesis of ventricular fibrillation," the deleterious
effects of catecholamine excess probably relate to lipid
and Ca'· metabolism. An important unresolved question
is whether increased plasma or tissue free fatty acid
concentrations, or both, are good or bad either for the
normal or for the ischaemic myocardium. There is a
variety of mechanisms by which increased tissue fatty
acids could adversely affect myocardial functions."·"''''
Such fatty acids may be acylated to form long-chain
acyl CoA esters, or they may react with intracellular
cations to form soaps. Possible results of this are non-
specific detergent effects on membranes and enzymes,
while an effective reduction in ionic Ca'· at crucial
cellular sites could affect Ca'·-dependent contraction events.
Free fatty acids also influence mitochondrial oxidative
phosphorylation," while they could conceivably cause
lability of other types of membranes. The significant role
of free fatty acids has further been emphasised by the
beneficial effect of nicotinic acid, administered as an
inhibitor of lipolysis, on the myocytolytic lesions induced
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Fig. 7. Proposed mechanisms of catecholamine-mediated
myocardial cell damage during ischaemia.
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thin filament interaction"'). Excessive systemic liberation of
catecholamines, however, as found for example in phaeo-
chromocytoma, tetanus, and isoproterenol injection, causes
a typical cardiomyopathy consisting of focal myocytolytic
lesions.'" Increased levels of circulating catecholamines
have also been found in patients with myocardial infarction"
and in experimental ischaemia," and the infarcted area
itself has been implicated as the source of catecholamines
which appear in the plasma."
Using isolated rat hearts, we have been able to demon-
strate effects caused by endogenous catecholamine release
during low-pressure perfusions. These released amines
have been detected by cellular effects rather than by direct
chemical analysis. We have also found in the hearts that
hormone-sensitive lipases, different from the well-known
lipoprotein lipase, undergo catecholamine-mediated stimu-
lation that is probably cA lP-dependent and thus similar to
analogous enzymes in adipose tissue." However, all the
effects of ischaemia on lipase activities in the isolated
hearts could not be explained only on the basis of
catecholamine release. In contrast to the in vitro stimulation
by epinephrine of the supernatant lipase acting on tribu-
tyrin, inhibition of this enzyme was observed during ischae-
mia (Fig. 2). Furthermore. this inhibition was not affected
by pre-perfusion reserpinisation, thus excluding catechola-
Fig. 6. The effect of reserpine pretreatment on lipase
activities in control (C) and ischaemic (I) hearts.
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by isoproterenol." The in vivo observations suppor-ting
ffiis general hypothesis include a positive corndation
between plasma free fatty acid conclwtratiofls and the
development of postinfarction arrhymmfas. left ventricular
failure and hypotension. The role of endogenous cardiac
fatty acid production in these processes remains to be
investigated.
The other ill-effects of catecholamine release relate to
the Ca" metabolism of f'he heart. Cardiac microsomes
contain intrinsic cAMP-dependent protein kinase(s) and
phosphatases. which contribute to the regulation of Ca--
fluxes. H is postulated that the increased tran membrane
Ca'- influx induced by sympathomimetic amines could
cause: (a) exce sive activation of Ca'--dependent inlra-
cellular ATPases and / or (b) mitochondrial calcification.
swelling and functional deterioration resulting in a massive
c3eficiency of cardiac high-energy phosphates. which could
lead to structural damage as observed in ischaemia."'"
Experimental support for this hypothesis comes from the
beneficial effect on these lesions of calcitonin and EDTA
(decreasing extracellular Ca-- supply). Verapamil (restricting
transmembrane Ca'- conductivity). and Mg-- or K" salts
(inhibiting intramitochondrial Ca-- deposition)." All these
mechanisms are schematically represented in Fig. 7. al-
though the quantitative importance of the different ele-
ments needs to be explored in detail. since they may be
important in the pathophysiology of cardiac ischaemia
and of its serious complications.
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